{"slideshow_credits": null, "snippet": "Valiant Capital Management, a San Francisco-based hedge fund, and Aberdare Ventures have jointly acquired a 45 percent stake in a pharmacy benefits company, ePharma, for an estimated 169 million reais ($74.6 million).", "abstract": "Valiant Capital Management, a San Francisco-based hedge fund, and Aberdare Ventures have jointly acquired a 45 percent stake in a pharmacy benefits company, ePharma, for an estimated 169 million reais ($74.6 million).", "section_name": "Business Day", "print_page": null, "document_type": "blogpost", "byline": {"person": [{"firstname": "Vinod", "role": "reported", "lastname": "SREEHARSHA", "rank": 1, "organization": ""}], "original": "By VINOD SREEHARSHA"}, "web_url": "http://dealbook.nytimes.com/2013/07/11/valiant-leads-investment-round-in-brazilian-pharmacy-benefits-firm/", "lead_paragraph": null, "headline": {"main": "Valiant Leads Investment Round in Brazilian Pharmacy Benefits Firm", "kicker": "DealBook"}, "_id": "51df39447e0d9c0839d2f4dd", "word_count": "434", "multimedia": [], "pub_date": "2013-07-11T18:56:29Z", "source": "The New York Times", "news_desk": null, "keywords": [{"name": "persons", "value": "Hansen, Christopher R", "rank": "1"}, {"name": "glocations", "value": "Brazil", "rank": "1"}, {"name": "subject", "value": "Drugs (Pharmaceuticals)", "rank": "1"}, {"name": "subject", "value": "Venture Capital", "rank": "2"}], "blog": [], "subsection_name": "Dealbook", "type_of_material": "Blog"}